A Clinical Trial comparing a Low Dose of Dexmeditomidine with other conventional sedatives for better comfort of patients during surgeries done under regional anesthesia

COMPARISON OF LOW DOSE DEXMEDITOMIDINE VERSUS CONVENTIONAL SEDATIVES FOR INTRAVENOUS SEDATION IN PATIENTS UNDERGOING SURGERIES UNDER REGIONAL ANESTHESIA

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/05/067937

Enrollment

120

Registered

2024-05-27

Start date

Unknown

Completion date

Unknown

Last updated

2024-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Group A Dexmedetomidine: A single dose of Dexmedetomidine 0.5mcg/kg given as intravenous infusion over 30 minutes Control Intervention1: 1. DEXMEDITOMIDINE group A 2. MIDAZOLAM PENTAZOS

Eligibility

Inclusion criteria

Inclusion criteria: Patients of ASA 1,2 and 3 Elective surgeries under regional anesthesia

Exclusion criteria

Exclusion criteria: cardiac diseases IHD CAD respiratory diseases COPD ILD Asthma neuropsychiatric disorders Obese patients Obstructive sleep apnea Difficult airway and intubation Children and pregnant patients

Design outcomes

Primary

Measure	Time frame
pain and sedation scores in perioperative periodTimepoint: 12 hours	—

Secondary

Measure	Time frame
Duration of Analgesia in the Post operative period Patient sedation scores & satisfaction Timepoint: Assessed at 3 6 9 & 12 HOURS	—

Countries

India

Contacts

Public ContactDr. Shirley Stephen

DepartRajiv Gandhi Institute of Medical Sciences Adilabad Telangana 504001

shirl_jip@yahoo.co.in9488651342

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026